Comments on: HIStalk Interviews Barry Chaiken

By: Rosy Snipples

Rosy Snipples — Wed, 21 Jul 2010 12:15:57 +0000

Criticisms by MIMD/Suzy are also true for paper charting.

By: Suzy, RN

Suzy, RN — Tue, 20 Jul 2010 23:41:14 +0000

I was asked by Patient Safety, MD, about what “axe” I have to grind. Another astute question was why report to the FDA. There is a law called the Federal Food Drug and Cosmetic Act that protects the safety of people from drugs and devices. The problem reported was caused by defective software running a device that ordered the incorrect test. These devices have been known to break down, have been known to misidentify, have been known to cause malpractice, have been known to disrupt chronology, have been known to generate errors, have been known to cause patient injury, have been knon to cause patient death, have been know ny day to day users to have more defects than are reported to public repositories of defects, of which the FDA is pre-emminent, and are known to cause data to go missing, all of which are grinders to sharpen my axe.

The wonderful interview above reveals more on the inner workings of the HIT industry. Thank you Mr. HIStalk, and thank you Dr. Chaiken.

By: anon

anon — Tue, 20 Jul 2010 15:33:28 +0000

not tired of suzy rn Says:

it is sad that the IT thought leaders have such misunderstanding of the complexities of medical care.

This person is an MD…

By: not tired of suzy rn

not tired of suzy rn — Tue, 20 Jul 2010 14:42:27 +0000

This is not exactly whast doctors do professionally: “We should be able to move in the clinical space where physicians and nurses and others are doing their skill set around pattern recognition and treating the patients. IT is the source of that.”

It is sad tha the IT thought leaders have such misunderstanding of the complexities of medical care.

By: MIMD

MIMD — Tue, 20 Jul 2010 14:30:46 +0000

We’re still learning, in healthcare, about that user interface. We’re still learning about how to put the applications together in a clinical workflow that’s going to be valuable to the patients and to the people who are providing care. Let’s be patient. Let’s give them a chance to figure out the right way to do this. Let’s give the application providers an opportunity to make this better.

II agree, we’re still learning about experimental devicesl.

These sentiments about “being patient” might have been appropriate – if the subjects of these experimental devices were lab rats, not mothers, fathers, sons, daughters, and … you get the idea.